20.02.2018 21:30:00
|
Lilly to Participate in Cowen Health Care Conference
INDIANAPOLIS, Feb. 20, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Cowen and Company 38th Annual Health Care Conference on Tuesday, March 13, 2018. Sue Mahony, Ph.D., senior vice president and president of Lilly Oncology and Levi Garraway, M.D., Ph.D., senior vice president of global development and medical affairs for Lilly Oncology will participate in a fireside chat at 8:00 a.m., Eastern Time.
A live audio webcast will be available on the "Webcasts & Presentations" section of Lilly's Investor website at http://investor.lilly.com/events.cfm. A replay of the presentation will be available on this same website for approximately 90 days.
About Eli Lilly and Company
Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels. F-LLY
Refer to: | Lauren Zierke; lauren_zierke@lilly.com; (317) 277-6524 (Media) |
Kevin Hern; hern_kevin_r@lilly.com; (317) 277-1838 (Investors) |
View original content with multimedia:http://www.prnewswire.com/news-releases/lilly-to-participate-in-cowen-health-care-conference-300601427.html
SOURCE Eli Lilly and Company
![](https://images.finanzen.at/images/unsortiert/wertpapierdepot-absichern-aktienchart-boerse-750493204-260.jpg)
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Eli Lillymehr Nachrichten
06.02.25 |
Eli Lilly-Aktie im Plus: Lilly übertrifft Erwartungen für Schlussquartal 2024 - Prognose bestätigt (dpa-AFX) | |
06.02.25 |
Eli Lilly expects to beat profit forecasts on obesity drug demand (Financial Times) | |
06.02.25 |
Ausblick: Eli Lilly legt Quartalsergebnis vor (finanzen.net) | |
04.02.25 |
S&P 500-Titel Eli Lilly-Aktie: So viel Gewinn hätte eine Eli Lilly-Investition von vor einem Jahr eingebracht (finanzen.at) | |
28.01.25 |
S&P 500-Titel Eli Lilly-Aktie: So viel Gewinn hätte eine Investition in Eli Lilly von vor 10 Jahren abgeworfen (finanzen.at) | |
22.01.25 |
Erste Schätzungen: Eli Lilly stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
21.01.25 |
S&P 500-Papier Eli Lilly-Aktie: So viel Gewinn hätte ein Eli Lilly-Investment von vor 5 Jahren abgeworfen (finanzen.at) | |
17.01.25 |
Aufschläge in New York: S&P 500 klettert zum Handelsende (finanzen.at) |
Analysen zu Eli Lillymehr Analysen
20.12.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
31.10.24 | Eli Lilly Buy | Jefferies & Company Inc. | |
13.02.24 | Eli Lilly Buy | Jefferies & Company Inc. |
Aktien in diesem Artikel
Eli Lilly | 851,70 | -0,15% |
|